5'-adenylyl (beta,gamma-methylene)diphosphonate has been researched along with pyridoxal phosphate in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; Jarvis, MF; Williams, M | 1 |
Cazenave, JP; Gachet, C; Hechler, B; Léon, C; Leray, C; Vial, C | 1 |
Cunningham, JR; Dent, Z; Neal, MJ | 1 |
Cinkilic, O; Jankowski, J; Schlüter, H; Tepel, M; van der Giet, M; Zidek, W | 1 |
Dickenson, AH; Kontinen, VK; Stanfa, LC | 1 |
Kimura, J; Matsuoka, I; Ohkubo, S | 1 |
Erdélyi, F; Sperlágh, B; Szabó, G; Vizi, ES | 1 |
Hennessey, TM; Wood, CR | 1 |
da Silva, BM; de Mendonça, A; Ribeiro, JA | 1 |
Asai, H; Nagamine, K; Ozaki, N; Shinoda, M; Sugiura, Y | 1 |
Cho, H; Choi, YM; Chung, S; Jang, JY; Jang, M; Kang, YK; Kim, SH; Park, MK | 1 |
1 review(s) available for 5'-adenylyl (beta,gamma-methylene)diphosphonate and pyridoxal phosphate
Article | Year |
---|---|
Purine and pyrimidine (P2) receptors as drug targets.
Topics: Adenosine Triphosphate; Animals; Drug Design; Humans; Ligands; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Uridine Triphosphate | 2002 |
10 other study(ies) available for 5'-adenylyl (beta,gamma-methylene)diphosphonate and pyridoxal phosphate
Article | Year |
---|---|
The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Binding, Competitive; Blood Platelets; Calcium; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Jurkat Cells; Megakaryocytes; Membrane Proteins; Polymerase Chain Reaction; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Suramin | 1997 |
Modulation of extracellular GABA levels in the retina by activation of glial P2X-purinoceptors.
Topics: Adenosine; Adenosine Triphosphate; Animals; Female; gamma-Aminobutyric Acid; Male; Neuroglia; Neuropeptides; Platelet Aggregation Inhibitors; Potassium Chloride; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rana temporaria; Rats; Rats, Wistar; Receptors, Purinergic P2X2; Retina; Thionucleotides | 1998 |
Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.
Topics: Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Perfusion; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Renal Artery; Renal Circulation; Suramin; Vasoconstriction; Vasoconstrictor Agents | 1999 |
Effects of spinally administered P2X receptor agonists and antagonists on the responses of dorsal horn neurones recorded in normal, carrageenan-inflamed and neuropathic rats.
Topics: Adenosine Triphosphate; Animals; Carrageenan; Electrophysiology; Inflammation; Injections, Spinal; Male; Nerve Fibers; Nerve Fibers, Myelinated; Neurons; Peripheral Nervous System Diseases; Platelet Aggregation Inhibitors; Posterior Horn Cells; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Spinal Nerves; Suramin | 2000 |
Ecto-alkaline phosphatase in NG108-15 cells : a key enzyme mediating P1 antagonist-sensitive ATP response.
Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Alkaline Phosphatase; Animals; Cyclic AMP; Gene Expression Regulation, Enzymologic; Glycerophosphates; Hydrogen-Ion Concentration; Hydrolysis; Levamisole; Mice; Organophosphates; Purinergic P1 Receptor Antagonists; Pyridoxal Phosphate; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity; Time Factors; Tumor Cells, Cultured | 2000 |
Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cadmium; Dose-Response Relationship, Drug; Electric Stimulation; Gene Expression; Guinea Pigs; Heart Atria; Hippocampus; In Vitro Techniques; Male; Norepinephrine; omega-Conotoxin GVIA; Presynaptic Terminals; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Receptors, Purinergic P2; RNA; Superior Cervical Ganglion; Tetrodotoxin; Theobromine; Thionucleotides; Time Factors; Tritium; Xanthines | 2000 |
PPNDS is an agonist, not an antagonist, for the ATP receptor of Paramecium.
Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Binding, Competitive; Calcium; Membrane Potentials; Paramecium; Phosphorus Radioisotopes; Purinergic P2 Receptor Agonists; Pyridoxal Phosphate; Receptors, Purinergic P2; Sulfonic Acids; Swimming | 2003 |
Long-term depression is not modulated by ATP receptors in the rat CA1 hippocampal region.
Topics: Adenosine Triphosphate; Animals; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; Male; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Receptors, Purinergic P2; Synaptic Transmission; Time Factors; Xanthines | 2005 |
Changes in P2X3 receptor expression in the trigeminal ganglion following monoarthritis of the temporomandibular joint in rats.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Arthritis; Cell Count; Drug Interactions; Facial Pain; Freund's Adjuvant; Functional Laterality; Immunohistochemistry; Male; Neurons; Pain Threshold; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Inbred Lew; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Stilbamidines; Temporomandibular Joint Disorders; Time Factors; Trigeminal Ganglion | 2005 |
Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Calcium; Central Nervous System Agents; Cytoplasm; Dopamine; In Vitro Techniques; Neurons; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Suramin; Thionucleotides | 2009 |